CELYSTRA Pharma

Montreal, Canada

CELYSTRA Pharma identifies, licenses, and commercializes innovative therapies for rare and underserved diseases in Canada.

$14.7M raised

May 2026

Seed

Biopharma Biotechnology Health Care Life Science Medical

Top Investors

Investissement Quebec Crédit Mutuel Equity

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about CELYSTRA Pharma

How much funding has CELYSTRA Pharma raised?

CELYSTRA Pharma has raised $14.7M in total funding. The most recent round was Seed. The last funding was announced in May 2026.

Who are CELYSTRA Pharma's investors?

CELYSTRA Pharma's investors include Investissement Quebec, Crédit Mutuel Equity.

Where is CELYSTRA Pharma headquartered?

CELYSTRA Pharma is headquartered in Montreal, Canada.

What does CELYSTRA Pharma do?

CELYSTRA Pharma identifies, licenses, and commercializes innovative therapies for rare and underserved diseases in Canada.

What stage is CELYSTRA Pharma at?

CELYSTRA Pharma is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 5, 2026.

MLA

"CELYSTRA Pharma — Funding & Investors." VCBacked, May 5, 2026, https://www.vcbacked.co/company/celystra-pharma. Accessed July 2, 2026.

APA

VCBacked. (2026). CELYSTRA Pharma — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/celystra-pharma

Wikipedia (cite web)

{{cite web |title=CELYSTRA Pharma — Funding & Investors |url=https://www.vcbacked.co/company/celystra-pharma |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 5, 2026.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.